Allos Therapeutics (ALTH) merges with AMAG Pharmaceuticals (AMAG) in a $686M all-stock deal. The...

|About: Allos Therapeutics, Inc. (ALTH)|By:, SA News Editor

Allos Therapeutics (ALTH) merges with AMAG Pharmaceuticals (AMAG) in a $686M all-stock deal. The combined firm expects to realize annual cost savings synergies of between $55 million and $60 million, primarily in the first fiscal year after closing. Shares of ALTH +9.2% premarket.